Auto-targeted neurostimulation is not superior to placebo in chronic low back pain: A fourfold blind randomized clinical trial

Keyphrases

• Belgium 20%
• Between-group 20%
• Brussels 20%
• Central Sensitization Pain 40%
• Chronic Low Back Pain (cLBP) 100%
• Chronic Nonspecific Low Back Pain 80%
• Clinically Significant 20%
• Health Beliefs 60%
• Health Centers 20%
• Hospital Care 20%
• Kinesiophobia 20%
• Low Back muscle 20%
• Mechanical Pressure 40%
• Musculoskeletal Pain 20%
• Myofascial Trigger Points (MTrPs) 80%
• Neurostimulation 100%
• Neurostimulator 100%
• No Significant Difference 20%
• Pain Behavior 40%
• Pain Catastrophizing 40%
• Pain Management 20%
• Pharmacy 20%
• Placebo 100%
• Placebo Groups 40%
• Placebo Treatment 20%
• Potential Treatments 20%
• Pressure Groups 20%
• Primary Outcome Measure 20%
• Randomized Clinical Trial 100%
• Randomized Controlled Trial 20%
• Transcutaneous Electrical Nerve Stimulation 40%
• Treatment Protocol 20%
• Treatment Session 20%
• University Hospital 20%

Medicine and Dentistry

• Analgesia 16%
• Back Muscle 16%
• Health Belief 50%
• Health Care 16%
• Low Back 16%
• Low Back Pain 100%
• Musculoskeletal Pain 16%
• Neurostimulation 100%
• Pain Catastrophizing 33%
• Placebo 100%
• Randomized Clinical Trial 100%
• Randomized Controlled Trial 16%
• Sensitization 33%
• Transcutaneous Electrical Nerve Stimulation 33%
• Trigger Point 66%

Neuroscience

• Behavior (Neuroscience) 33%
• Catastrophizing 33%
• Neurostimulation 100%
• Placebo 100%
• Randomized Controlled Trial 16%